NanoEcho AB
Develops a diagnostic method for rectal cancer to assess lymph node spread.
NANECH | ST
Overview
Corporate Details
- ISIN(s):
- SE0017133705
- LEI:
- 894500C46ZR7PVT2LU02
- Country:
- Sweden
- Address:
- Scheelevägen 19, 223 63 Lund
- Website:
- https://nanoecho.se/
- Sector:
- Manufacturing
Description
NanoEcho AB is a medical technology company developing a novel diagnostic method for early-stage rectal cancer. The company's technology is designed to accurately determine if cancer has spread to nearby lymph nodes, a critical factor for treatment planning. The patented method utilizes a combination of iron oxide-based nanoparticles as a contrast agent, a magnetic field, and advanced ultrasound to generate high-resolution images. By improving diagnostic precision, NanoEcho aims to enable more individualized treatment strategies, potentially reducing the number of unnecessary major surgical interventions. This approach seeks to enhance patient quality of life, optimize healthcare resources, and provide significant health economic benefits.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NanoEcho AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NanoEcho AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NanoEcho AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
